Articles written by Globe Newswire - Benzinga

Biz2Credit's Annual Top 25 Cities for Small Business Report Identifies Worcester, MA as #1

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- The 2025 Biz2Credit Top Cities for Small Business Study has identified Worcester, MA, as the top city for small businesses in its annual financial analysis. According to

UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025Diluted EPS of $4.29 in fiscal 2025; Adjusted fiscal 2025 Diluted EPS of $4.52 grew 7.4% versus

Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative

Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the

Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

ALPHARETTA, Ga., May 08, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD) ("Clearside" or the "Company"), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye

Axogen, Inc. Reports 2025 First Quarter Financial Results

ALACHUA, Fla. and TAMPA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported

Appian Announces First Quarter 2025 Financial Results

MCLEAN, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN) today announced financial results for the first quarter ended March 31, 2025. "In Q1, Appian continued to demonstrate our earnings potential, with

Invivyd to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025

WALTHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (NASDAQ:IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it will host a

Black Diamond Group Limited Announces Renewal of Normal Course Issuer Bid

CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (TSX:BDI, OTCQX:BDIMF) ("Black Diamond" or the "Company") announces that it has obtained approval of the Toronto Stock Exchange (the "TSX")

Dave Reports First Quarter 2025 Financial Results

Q1 Revenue Hits $108.0 Million, Representing Accelerating Growth of 47% Y/Y Q1 Net Income Reaches $28.8 Million; Adj. EBITDA Increases 235% Y/Y to $44.2 Million Raises 2025 Revenue and Adj. EBITDA Guidance to

LENSAR Reports First Quarter 2025 Results and Provides Business Update

14 ALLY Robotic Laser Cataract Systems™ ("ALLY Systems") placed in 1Q 2025 with an additional backlog of 24 systems pending installation as of March 31, 2025 34% Revenue growth over the first quarter

HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

$159.5 million of cash, cash equivalents and marketable securities as of March 31, 2025 The company is exploring the potential for continued development of its norovirus vaccine candidates inadults as well as business

Allegro MicroSystems Reports Fourth Quarter and Fiscal Year 2025 Results

MANCHESTER, N.H., May 08, 2025 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. ("Allegro" or the "Company") (NASDAQ:ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy

BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

NESS ZIONA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates

Primary endpoint met in Phase 2b trial with GH001 in TRD demonstrating -15.5 Point placebo-adjusted MADRS reductionFull response to the IND hold on track for submission in mid-2025Cash, cash equivalents, other financial

Lee Enterprises Reports Second Quarter Results

Total Digital Revenue(1) of $73M represented 53% of total revenue Digital-Only subscription revenue increased 20% YOY(2) Amplified Digital® Agency revenue totaled $25M, or up 9% YOY(2) DAVENPORT, Iowa, May 08,

Malibu Boats, Inc. Announces Third Quarter Fiscal 2025 Results

LOUDON, Tenn., May 08, 2025 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. (NASDAQ:MBUU) today announced its financial results for the third quarter ended March 31, 2025. Third Quarter Fiscal 2025 Highlights Compared to Third

Peloton Interactive, Inc. Reports Third Quarter Fiscal 2025 Financial Results

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ:PTON) has announced its financial results for the third quarter of fiscal 2025. Please visit the Peloton investor relations website to view

Conavi Medical's Novasight Hybrid™ System Named "Product Innovation of the Year" at 2025 Minnesota Manufacturing Awards

TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV:CNVI, OTCQB:CNVIF) ("Conavi Medical" or the "Company"), a medical device company focused on designing, manufacturing, and marketing imaging

Plus Therapeutics to Participate in the D. Boral Capital Inaugural Global Conference

HOUSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for

Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

Company received approval from European Medicines Agency (EMA) for CLN-978; Phase 1 study in active, difficult-to-treat rheumatoid arthritis to initiate in Q2 2025 CLN-978 expands into Sjögren's disease; Phase 1 study